Table 2.
Additional benefit: considerable | |||||
Indication class by ICD-10 | n | Mean | Min | Max | SD |
Certain infectious and parasitic diseases | 11 | 23.80 | 10.07 | 42.54 | 13.96 |
Diseases of the circulatory system | 1 | 19.35 | 19.35 | 19.35 | – |
Diseases of the eye and adnexa | 1 | 15.43 | 15.43 | 15.43 | – |
Diseases of the musculoskeletal system and connective tissue | 1 | 39.44 | 39.44 | 39.44 | – |
Endocrine, nutritional and metabolic diseases | 1 | 5.05 | 5.05 | 5.05 | – |
Neoplasms | 14 | 18.44 | 6.35 | 35.19 | 8.69 |
Overall | 29 | 20.66 | 5.05 | 42.54 | 11.55 |
Size of target population (upper level) | 29 | 18172 | 143 | 221000 | 40788 |
Additional benefit: minor | |||||
Indication class by ICD-10 | n | Mean | Min | Max | SD |
Certain infectious and parasitic diseases | 12 | 18.48 | 0.00 | 42.54 | 13.78 |
Diseases of the circulatory system | 6 | 29.97 | 4.65 | 58.73 | 20.21 |
Diseases of the digestive system | 1 | 25.54 | 25.54 | 25.54 | – |
Diseases of the genitourinary system | 2 | 19.80 | 19.80 | 19.80 | 0.00 |
Diseases of the nervous system | 2 | 40.69 | 29.71 | 51.67 | 15.53 |
Diseases of the respiratory system | 2 | 2.01 * | 2.01 | 2.01 | 0.00 |
Endocrine, nutritional and metabolic diseases | 10 | 15.02 | 1.00 | 25.31 | 7.36 |
Neoplasms | 12 | 23.16 | 4.74 | 46.44 | 12.83 |
Other | 1 | 24.50 | 24.50 | 24.50 | – |
Overall | 48 | 20.93 | 0.00 | 58.73 | 20.16 |
Size of target population (upper level) | 48 | 153723 | 6 | 2542810 | 425313 |
Additional benefit: non-quantifiable | |||||
Indication class by ICD-10 | n | Mean | Min | Max | SD |
Certain infectious and parasitic diseases | 6 | 16.86 | 10.07 | 21.25 | 5.33 |
Diseases of the circulatory system | 1 | 19.35 | 19.35 | 19.35 | – |
Diseases of the digestive system | 1 | 14.87 | 14.87 | 14.87 | – |
Diseases of the respiratory system | 1 | 10.96 | 10.96 | 10.96 | – |
Neoplasms | 11 | 18.84 | 9.00 | 29.78 | 6.29 |
Other | 2 | 13.64 | 13.64 | 13.64 | 0.00 |
Overall | 22 | 17.31 * | 9.00 | 29.778 | 55.32 |
Size of target population (upper level) | 22 | 6081 | 25 | 34000 | 9994 |
No additional benefit | |||||
Indication class by ICD-10 | n | Mean | Min | Max | SD |
Certain infectious and parasitic diseases | 22 | 24.45 | 3.16 | 42.54 | 11.01 |
Diseases of the digestive system | 4 | 31.02 | 31.02 | 31.02 | 0.00 |
Diseases of the blood and blood-forming organs | 2 | 24.50 | 23.15 | 25.85 | 1.91 |
Diseases of the circulatory system | 6 | 22.49 | 4.65 | 49.52 | 14.69 |
Diseases of the eye and adnexa | 6 | 20.13 | 3.06 | 78.02 | 29.04 |
Diseases of the nervous system | 7 | 37.03 | 24.32 | 67.30 | 15.26 |
Diseases of the respiratory system | 6 | 16.90 | 2.01 | 25.74 | 11.60 |
Diseases of the skin and subcutaneous tissue | 1 | 42.75 | 42.75 | 42.75 | – |
Endocrine, nutritional and metabolic diseases | 13 | 24.72 * | 12.78 | 48.60 | 13.86 |
Mental and behavioral disorders | 2 | 25.68 | 17.36 | 34.00 | 11.77 |
Neoplasms | 19 | 20.43 | 0.00 | 53.71 | 13.92 |
Other | 4 | 25.10 * | 21.65 | 28.55 | 3.98 |
Overall | 92 | 24.25 * | 0.00 | 78.02 | 14.18 |
Size of target population (upper level) | 92 | 170203 | 15 | 3253000 | 499215 |
Abbreviations: Min minimum, Max maximum, SD standard deviation
All discounts presented in %
Assessment with “Major Benefit” = 13.64 % (TP upper level = 2333.33)
Assessment with “Less Benefit” = 9.00 % (TP upper level = 1460)
* p < 0.05 compared to mean discount of the other indications